Your browser doesn't support javascript.
loading
Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 - 2018.
Guggenbühl Noller, Jessica Michelle; Froeschl, Guenter; Eisermann, Philip; Jochum, Johannes; Theuring, Stefanie; Reiter-Owona, Ingrid; Bissinger, Alfred Lennart; Hoelscher, Michael; Bakuli, Abhishek; von Sonnenburg, Franz-Josef Falkner; Rothe, Camilla; Bretzel, Gisela; Albajar-Viñas, Pedro; Grout, Lise; Pritsch, Michael.
Afiliação
  • Guggenbühl Noller JM; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Froeschl G; Center for International Health, University Hospital, LMU Munich, Munich, Germany.
  • Eisermann P; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany. froeschl@lrz.uni-muenchen.de.
  • Jochum J; Center for International Health, University Hospital, LMU Munich, Munich, Germany. froeschl@lrz.uni-muenchen.de.
  • Theuring S; National Reference Centre for Tropical Pathogens, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Reiter-Owona I; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Bissinger AL; Institute of Tropical Medicine and International Health, Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Hoelscher M; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
  • Bakuli A; Institute of Tropical Medicine, Medical Department, University Hospital Tübingen, Tübingen, Germany.
  • von Sonnenburg FF; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Rothe C; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Bretzel G; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Albajar-Viñas P; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Grout L; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Pritsch M; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
BMC Infect Dis ; 20(1): 919, 2020 Dec 03.
Article em En | MEDLINE | ID: mdl-33272201
ABSTRACT

BACKGROUND:

The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost two decades was collected and analysed.

METHODS:

German laboratories offering diagnostics for chronic Trypanosoma cruzi (T. cruzi) infection in routine patient care were identified. All retrievable data on tests performed during the years of 2000-2018 were analysed. Additional clinical information regarding patients diagnosed with CD was collected through questionnaires.

RESULTS:

Five German laboratories with diagnostics for T. cruzi infection in routine patient care were identified. Centres in Hamburg and Munich offered two independent serological tests to confirm the CD diagnosis, as recommended by WHO during the entire time period 2000-2018. Overall, a total of n = 10,728 independent tests involving n = 5991 individuals were identified with a progressive increase in testing rates over time, only n = 130 (16.0%) of the tested individuals with known nationality came from CD endemic countries. Of all test units conducted at the included institutes, a total of n = 347/10,728 (3.2%) tests on CD were positive, of which n = 200/347 (57.6%) were ELISA, n = 133/347 (38.3%) IFT, n = 10/347 (2.9%) PCR, and n = 4/347 (1.2%) RDT. Of the n = 5991 individuals only n = 81 (1.4%) with chronic infection were identified, n = 52 females and n = 28 males. Additional clinical information could only be collected from n = 47.

CONCLUSION:

The results of this study give insight into the deployment of screening, detection, diagnosis, and treatment of T. cruzi over the last two decades in Germany and existing deficits therein; the creation of guidelines for Germany could be a step forward to improve the existing gaps.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trypanosoma cruzi / Programas de Rastreamento / Doença de Chagas Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trypanosoma cruzi / Programas de Rastreamento / Doença de Chagas Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article